A&P appoints vice chairman, chief strategy officer
MONTVALE, N.J. A&P has appointed Andreas Guldin as vice chairman and chief strategy officer. The move comes in the midst of the departure of president and CEO Eric Claus.
According to a filing with the Securities and Exchange Commission, Guldin assumed the new role on Oct. 15.
Guldin became a member of the board in May 2007. From May 1, 2007 to Oct. 14, 2009, Guldin was executive managing director, strategy & corporate development for the company.
As reported earlier this week by Drug Store News, Christian Haub, executive chairman of the board for A&P, has reassumed the CEO duties, a position he held from 1998 to 2005, while the company searches for a successor.
Schnuck exec honored by produce pub
ST. LOUIS A weekly newspaper serving the produce industry has given a top award to a Schnuck Markets executive.
The Packer named Schnucks VP produce and floral Michael O’Brien the 2009 “Marketer of the Year,” Schnucks announced, presenting him with the award at the Produce Marketing Association’s Fresh Summit earlier this month.
O’Brien has worked in the supermarket industry for 37 years, starting at Schnucks as a bagger in 1972, becoming a store manager in 1983 and division manager in 1990. He has served in his current position since 2001.
Schnucks said O’Brien had taken an “active role” in promoting produce consumption and was a member of a number of industry organizations. He is chairman-elect of the PMA’s board of directors and served as chairman of the Produce for Better Health Foundation in 2007, promoting that organizations “5 a day, Fruits & Veggies – More Matters” campaign to promote the eating of fruits and vegetables. Produce Merchandising magazine also named him “Retailer of the Year” in 2004.
AACE introduces diabetes algorithm
JACKSONVILLE, Fla. A new algorithm designed to help Type 2 diabetes patients achieve glycemic control has appeared online in the September/October edition of the journal Endocrine Practice.
The algorithm, released as a consensus statement by the American Association of Clinical Endocrinologists and the American College of Endocrinology is a one-page resource designed to assist primary care doctors, endocrinologists and others in the management of Type 2 diabetes.
“Depending on a patient’s current A1C level, a physician will use the algorithm to determine whether a mono-, dual- or triple-combination therapy should be considered,” former AACE president and co-chairwoman of the Algorithm Task Force Helena Rodbard said in a statement. “To minimize the risk of diabetic complications, the algorithm will help achieve a hemoglobin A1C value of 6.5 or less when appropriate.”
The task force said it was the first such algorithm that considers currently approved classes of medications emphasizing safety and efficacy while also considering factors such as the overall cost of care.